SailPoint outlines FY2029 targets including at least $2.1B ARR amid agentic AI push (NASDAQ:SAIL)September 9, 2026
Share Facebook Twitter LinkedIn Pinterest Email Urogen pharma outlines $1B revenue potential for UGN-102 with June 2025 launch target
SailPoint outlines FY2029 targets including at least $2.1B ARR amid agentic AI push (NASDAQ:SAIL)September 9, 2026
Chime Financial initiated with Buy at Loop Capital, price target set at $45 (CHYM:NASDAQ)September 9, 2026
By Press Room
By Press Room
By Press Room
